INS and metabolic dysfunction-associated steatohepatitis: GLP-1 receptor agonists liraglutide and semaglutide: Liraglutide and semaglutide are examples of GLP-1 receptor agonists which are antidiabetic agents that have been established as effective antidiabetic interventions in MASH owing to their interventional impacts in weight regression, insulin sensitivity, and hepatic metabolism.